Skip to content

Addiction: all studies

Page 508 of 861: studies 5,071 to 5,080 of 8,603, newest first. Back to the addiction overview

Research

"Hot" and "Cold" Cognition in Users of Club Drugs/Novel Psychoactive Substances.

Frontiers in Psychiatry March 24, 2021 George Savulich, Owen Bowden-Jones, Robert Stephenson et al.

Novel psychoactive substances (NPS) are popular "club/party" drugs that first attracted attention in the UK in 2009 and remained legal until the 2016 Psychoactive Substances Act criminalized their distribution. Unlike "traditional" illicit drugs, very little is known about the influence of their analogs on neuropsychological functioning. We characterized the cognitive and emotional profile of...

DOI: 10.3389/fpsyt.2021.660575 (opens in new tab) Full text (opens in new tab) Neuropsychology Emotion Drug addiction Legal highs +2

Acute Pharmacological Effects and Oral Fluid Biomarkers of the Synthetic Cannabinoid UR-144 and THC in Recreational Users

Biology March 24, 2021 Nunzia La Maida, Esther Papaseit, Lucía Martínez de Soto et al. 14 citations

Synthetic cannabinoids (SCs) are one of the most frequent classes of new psychoactive substances monitored by the EU Early Warning System and World Health Organization. UR-144 is a SC with a relative low affinity for the CB1 receptor with respect to that for the CB2 receptor. As with other cannabinoid receptor agonists, it has been monitored by the EU Early Warning System since 2012 for severe...

DOI: 10.3390/biology10040257 (opens in new tab) Cannabis Heart rate Cannabinoid receptor Blood pressure +4

Using Microdosing to Induct Patients Into a Long-Acting Injectable Buprenorphine Depot Medication in Low Threshold Community Settings: A Case Study

Frontiers in Pharmacology March 23, 2021 Joseph Tay Wee Teck, Alexander Baldacchino, Lauren Gibson et al.

Healthcare innovation has never been more important as it is now when the world is facing up to the unprecedented challenges brought by the COVID-19 pandemic. Within addictions services in Scotland, the priority has been to tackle our rising drug related death rate by maintaining and improving access to treatment while protecting frontline workers and managing operational challenges as a result...

Depression treatment response to ketamine: sex-specific role of interleukin-8, but not other inflammatory markers

Translational Psychiatry March 21, 2021 Jennifer L. Kruse, Megha M Vasavada, Richard Olmstead et al. 47 citations

Abstract Inflammation plays a role in depression pathophysiology and treatment response, with effects varying by sex and therapeutic modality. Lower levels of interleukin(IL)-8 predict depression response to antidepressant medication and to electroconvulsive therapy (ECT), although ECT effects are specific to females. Whether IL-8 predicts depression response to ketamine and in a sex-specific...

Brain network integration dynamics are associated with loss and recovery of consciousness induced by sevoflurane

Human Brain Mapping March 19, 2021 Andrea I. Luppi, Daniel Golkowski, Andreas Ranft et al. 72 citations

Abstract The dynamic interplay of integration and segregation in the brain is at the core of leading theoretical accounts of consciousness. The human brain dynamically alternates between a sub‐state where integration predominates, and a predominantly segregated sub‐state, with different roles in supporting cognition and behaviour. Here, we combine graph theory and dynamic functional...

DOI: 10.1002/hbm.25405 (opens in new tab) Default mode network Consciousness Dynamic functional connectivity Functional integration +4

Local Neuronal Synchronization in Frequent Nightmare Recallers and Healthy Controls: A Resting-State Functional Magnetic Resonance Imaging Study

Frontiers in Neuroscience March 18, 2021 Louis-Philippe Marquis, Sarah-Hélène Julien, Véronique Daneault et al. 6 citations

Nightmares are highly dysphoric dreams that are well-remembered upon awakening. Frequent nightmares have been associated with psychopathology and emotional dysregulation, yet their neural mechanisms remain largely unknown. Our neurocognitive model posits that nightmares reflect dysfunction in a limbic-prefrontal circuit comprising medial prefrontal and anterior cingulate cortices, hippocampus,...

DOI: 10.3389/fnins.2021.645255 (opens in new tab) Nightmare Unconsciousness Anterior cingulate cortex Resting State FMRI +5

Concomitant drugs associated with increased mortality for MDMA users reported in a drug safety surveillance database

Scientific Reports March 16, 2021 Isaac Cohen, Tigran Makunts, Ruben Abagyan et al. 30 citations

Abstract 3,4-Methylenedioxymethamphetamine (MDMA) is currently being evaluated by the Food and Drug Administration (FDA) for the treatment of post-traumatic stress disorder (PTSD). If MDMA is FDA-approved it will be important to understand what medications may pose a risk of drug–drug interactions. The goal of this study was to evaluate the risks due to MDMA ingestion alone or in combination...

Development of a physiologically based pharmacokinetic (PBPK) model of psilocybin and psilocin from magic mushroom in rats and humans

F1000Research March 15, 2021 Prinya Musikaphongsakul, Kimheang Ya, Pakpoom Subsoontorn et al. 6 citations

Background: Psilocybin (PB) is a psychoactive compound commonly found in magic mushroom (Psilocybe cubensis). PB is quickly converted by the body to psilocin (PI), which has a psychedelic effect through the activation of the 5-HT2A receptor in the brain. The objective of this study is to develop a physiologically based pharmacokinetic (PBPK) model of PB and PI in rats and humans for predicting...

DOI: 10.12688/f1000research.28133.1 (opens in new tab) Pharmacology Ns3 Pharmacokinetics

Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice

Frontiers in Psychology March 15, 2021 Ingmar Gorman, Ingmar Gorman, Ingmar Gorman et al.

Psychedelic Harm Reduction and Integration (PHRI) is a transtheoretical and transdiagnostic clinical approach to working with patients who are using or considering using psychedelics in any context. The ongoing discussion of psychedelics in academic research and mainstream media, coupled with recent law enforcement deprioritization of psychedelics and compassionate use approvals for...

DOI: 10.3389/fpsyg.2021.645246 (opens in new tab) Psilocybin Psychedelics Harm reduction Psychotherapy +11

Consciousness depends on integration between parietal cortex, striatum and thalamus

Cell Systems March 12, 2021 Mohsen Afrasiabi, Michelle J. Redinbaugh, Jessica M. Phillips et al.

SUMMARY: The neural substrates of consciousness remain elusive. Competing theories that attempt to explain consciousness disagree on the contribution of frontal versus posterior cortex and omit subcortical influences. This lack of understanding impedes the ability to monitor consciousness, which can lead to adverse clinical consequences. To test substrates and measures of consciousness, we...